Filter Results
Filter Results
General (55) Acquisitions (4) New Products (4) New Technologies (1) Partnerships (1)
2022 (3) 2021 (5) 2020 (5) 2019 (21) 2018 (18) 2017 (4) 2016 (2) 2015 (1)
English (59)
EnglishX
Showing 1‐10 of 59
News Release
01 Nov 2022
Lonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine
Lonza meets pressing market need by launching first ever coating-free capsule to support intestinal delivery of acid-sensitive APIs Innovative Capsugel® Enprotect™ capsule can...
News Release
09 May 2022
Lonza Expands its Capsugel® Capsule Offering to Include Titanium Dioxide-Free White Hard Gelatin Capsules
New hard gelatin capsule provides a bright white color, while meeting titanium dioxide-free requirements for foods in the European Union The new capsule features an...
News Release
23 Mar 2022
Christian Seufert appointed as President of Capsules and Health Ingredients Division
Lonza appoints Christian Seufert as President of the CHI Division and member of the Executive Committee Christian brings a unique level of experience and expertise from a...
News Release
30 Jun 2021
Kaged Muscle First to Launch with Lonza's TWK10 Sports Probiotic in the USA
Kaged Muscle is dedicated to providing premium sports nutrition supplements featuring high-quality, science-backed ingredientsTWK10® sports probiotic, brought to market by...
News Release
28 Apr 2021
New Study Shows Lonza’s Carniking® Premix Improves Protein Turnover, Maximum Energy Expenditure in Active Dogs
Recently published research shows that Carniking® premix improves lean muscle mass and supports efficient energy expenditure in active dogs
News Release
20 Apr 2021
Clinically Proven UC-II ® Undenatured Type II Collagen Made with Organic Collagen is Now Available for the US Organic Joint-Health Market
Quote from Martin Sambusini, Associate Director of Innovation, Lonza Capsules & Health Ingredients:“Right now, joint health is a key priority...
News Release
01 Apr 2021
Lonza Completes Divestment of Two Sites to NextPharma
Completion of sale of Lonza sites in Ploermel (FR) and Edinburgh (UK)A seamless ownership transfer process remains a priorityA French version of this release is also availableQuote...
News Release
19 Jan 2021
NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms
Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage...
News Release
17 Dec 2020
Body&Fit to Utilize Lonza's Comprehensive Capsule and Specialty Ingredients Portfolio to Expand Product Offering
Glanbia Performance Nutrition's direct-to-customer division Body&Fit to utilize Lonza's Duocap® capsule technologyBody&Fit plans to launch new products featuring Lonza's...
News Release
22 Oct 2020
Lonza Expands Its Capsule Manufacturing Capacity
Investment of CHF85m will expand capsule manufacturing capacity by 30 billion capsules annuallyThe new expansion involves eight global Lonza sitesThe investment aims to address the...
1 2 3 4 ... 6 >